Cargando…
Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer-related death. The demand for new therapeutic approaches has increased attention paid toward therapies with high targeting efficiency, improved selectivity and few side effects. Porphyrins are powerful molecules with exceptional properties and mul...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659284/ https://www.ncbi.nlm.nih.gov/pubmed/34885849 http://dx.doi.org/10.3390/molecules26237268 |
_version_ | 1784612928073236480 |
---|---|
author | Dandash, Fatima Leger, David Y. Diab-Assaf, Mona Sol, Vincent Liagre, Bertrand |
author_facet | Dandash, Fatima Leger, David Y. Diab-Assaf, Mona Sol, Vincent Liagre, Bertrand |
author_sort | Dandash, Fatima |
collection | PubMed |
description | Colorectal cancer (CRC) is a leading cause of cancer-related death. The demand for new therapeutic approaches has increased attention paid toward therapies with high targeting efficiency, improved selectivity and few side effects. Porphyrins are powerful molecules with exceptional properties and multifunctional uses, and their special affinity to cancer cells makes them the ligands par excellence for anticancer drugs. Porphyrin derivatives are used as the most important photosensitizers (PSs) for photodynamic therapy (PDT), which is a promising approach for anticancer treatment. Nevertheless, the lack of solubility and selectivity of the large majority of these macrocycles led to the development of different photosensitizer complexes. In addition, targeting agents or nanoparticles were used to increase the efficiency of these macrocycles for PDT applications. On the other hand, gold tetrapyrrolic macrocycles alone showed very interesting chemotherapeutic activity without PDT. In this review, we discuss the most important porphyrin derivatives, alone or associated with other drugs, which have been found effective against CRC, as we describe their modifications and developments through substitutions and delivery systems. |
format | Online Article Text |
id | pubmed-8659284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86592842021-12-10 Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer Dandash, Fatima Leger, David Y. Diab-Assaf, Mona Sol, Vincent Liagre, Bertrand Molecules Review Colorectal cancer (CRC) is a leading cause of cancer-related death. The demand for new therapeutic approaches has increased attention paid toward therapies with high targeting efficiency, improved selectivity and few side effects. Porphyrins are powerful molecules with exceptional properties and multifunctional uses, and their special affinity to cancer cells makes them the ligands par excellence for anticancer drugs. Porphyrin derivatives are used as the most important photosensitizers (PSs) for photodynamic therapy (PDT), which is a promising approach for anticancer treatment. Nevertheless, the lack of solubility and selectivity of the large majority of these macrocycles led to the development of different photosensitizer complexes. In addition, targeting agents or nanoparticles were used to increase the efficiency of these macrocycles for PDT applications. On the other hand, gold tetrapyrrolic macrocycles alone showed very interesting chemotherapeutic activity without PDT. In this review, we discuss the most important porphyrin derivatives, alone or associated with other drugs, which have been found effective against CRC, as we describe their modifications and developments through substitutions and delivery systems. MDPI 2021-11-30 /pmc/articles/PMC8659284/ /pubmed/34885849 http://dx.doi.org/10.3390/molecules26237268 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dandash, Fatima Leger, David Y. Diab-Assaf, Mona Sol, Vincent Liagre, Bertrand Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer |
title | Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer |
title_full | Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer |
title_fullStr | Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer |
title_full_unstemmed | Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer |
title_short | Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer |
title_sort | porphyrin/chlorin derivatives as promising molecules for therapy of colorectal cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659284/ https://www.ncbi.nlm.nih.gov/pubmed/34885849 http://dx.doi.org/10.3390/molecules26237268 |
work_keys_str_mv | AT dandashfatima porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer AT legerdavidy porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer AT diabassafmona porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer AT solvincent porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer AT liagrebertrand porphyrinchlorinderivativesaspromisingmoleculesfortherapyofcolorectalcancer |